<DOC>
	<DOCNO>NCT01978470</DOCNO>
	<brief_summary>The purpose study evaluate tolerability safety NeuroSigma eTNS system .</brief_summary>
	<brief_title>External Trigeminal Nerve Stimulation Drug Resistent Epilepsy</brief_title>
	<detailed_description>This study evaluate safety tolerability NeuroSigma eTNS system treatment drug resistent partial seizure . Up 20 subject , age 18 - 75 , partial epilepsy enrol acute 4-week tolerability study Olive View/UCLA Medical Center ... ... . Enrolled subject ask maintain accurate seizure calendar , see initial visit , two four week ... ... .</detailed_description>
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<criteria>Age 1865 Partial onset seizure ( complex partial secondary generalize tonicclonic ) At least one seizure every three month No serious progressive medical psychiatric illness At least one complex partial generalize tonicclonic seizure last three month MRI EEG consistent localizationrelated partial epilepsy Exposure least two antiepileptic drug adequate dos Concurrent use least one antiepileptic drug adequate dose No change antiepileptic drug dose least 30 day prior study enrollment Vagus nerve stimulation ( VNS ) History nonepileptic seizure Inability maintain accurate seizure calendar ( self caregiver ) Frequent use benzodiazepine seizure cluster define great four time per month History facial pain trigeminal neuralgia Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>epilepsy</keyword>
	<keyword>drug resistent epilepsy</keyword>
	<keyword>partial onset seizure</keyword>
	<keyword>trigeminal nerve stimulation</keyword>
	<keyword>neuromodulation</keyword>
</DOC>